
Shares of animal diagnostics maker IDEXX Laboratories IDXX.O rise 1.13% to $678.02 premarket
Co reports Q4 adj. profit of $3.08/shr vs analysts' average estimate of $2.93/shr - LSEG data
Brokerage Leerink Partners said non‑wellness vet visits, which drive most recurring diagnostics revenue, held up better than overall visit volumes in Q4
Co's quarterly revenue of $1.091 billion beats analysts' average expectation of $1.073 billion
Shares were up ~64% in 2025